热门公司

招聘

职位

Editas Medicine

Editas Medicine

Editas Medicine

Genome editing company

Gene Editing

CRISPR Technology

Genomic Medicine

Clinical Research

Rare Diseases

Cambridge, Massachusetts, United States

201-500

2013年成立(第13年)

混合办公

Public

估值

$1.2B

融资总额

$300M

EDIT

$3.49

营收 (2026)

$0

营业利润

$0

开放职位

0个职位

目前没有开放的职位

产品与服务

reni-cel

reni-cel

Gene Therapy

ED

EDIT-101

Gene Therapy

ED

EDIT-301

Cell Therapy

ED

EDIT-201

Gene Therapy

CR

CRISPR Gene Editing Platform

Technology Platform

In Vivo Gene Editing Medicines

In Vivo Gene Editing Medicines

Gene Therapy

IN

In Vivo Gene Editing Services

R&D Services

EX

Ex Vivo Cell Engineering

R&D Services

领导团队

CS

Charlene Stern

Executive Vice President & General Counsel

KB

Kevin Bitterman

Interim President

DRL

David R. Liu

Founder

FZ

Feng Zhang

Founder

总浏览量

0

申请点击数

0

模拟申请者数

0

收藏

0

评价

3.5

8条评价

工作生活平衡

3.8

薪酬

3.5

企业文化

3.2

职业发展

2.8

管理层

2.3

优点

Good benefits and compensation

Positive work environment

Interesting science and work

缺点

Poor upper management

Lack of direction and strategy changes

Management issues and poor leadership

薪资范围

37个数据点

Director

Director

1份报告

$195,000

年薪总额

基本工资

$150,000

股票

-

$195,000

$195,000

面试经验

39次面试

难度

3.4

/ 5

时长

2-5w

录用率

35%

体验

正面 67%

中性 15%

负面 18%

面试流程

1

Phone Screen

2

Technical Interview

3

Hiring Manager

4

Team Fit

联系方式与地址